Tuesday, 24 November 2020

Dr Reddy’s launches succinylcholine chloride injection

13 November 2020 | News

A therapeutic equivalent generic version of Quelicin® (Succinylcholine Chloride) Injection, 20 mg/mL, approved by US FDA

Source credit: Shutterstock

Source credit: Shutterstock

Dr Reddy’s Laboratories announced the launch of Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL), Multiple-Dose Vials a therapeutic equivalent generic version of Quelicin® (Succinylcholine Chloride) Injection, 20 mg/mL, approved by the US Food and Drug Administration (USFDA). 

The Quelicin® brand and generic market had US sales of approximately $74.8 million MAT for the most recent twelve months ending in September 2020 according to IQVIA Health.

Dr Reddy’s Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL), is available in multi-dose vials.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account